Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 14, 2017; 23(22): 3954-3963
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.3954
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.3954
Adverse effect | Frequency |
Increased gut permeability | 44%-70% |
Gut inflammation | 60%-70% |
Blood loss and anemia | 30% |
Malabsorption | 40%-70% |
Mucosal ulceration | 30%-40% |
Protein loss | 10% |
Mucosal ulceration | 30%-40% |
Complications requiring hospitalizations | 0.3%-0.9% |
Diaphragms of the small bowel | < 1% |
- Citation: Utzeri E, Usai P. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(22): 3954-3963
- URL: https://www.wjgnet.com/1007-9327/full/v23/i22/3954.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i22.3954